A population pharmacokinetic model based on HPTN 077 of long-acting injectable cabotegravir for HIV PrEP.

Yifan YuKristin L BigosMark A MarzinkeRaphael J LandovitzMarybeth McCauleySusan FordCraig W HendrixRobert R BiesEthel D Weldnull null

Published in: British journal of clinical pharmacology (2022)

The public availability of this model will facilitate and enable a wide variety of future clinically relevant simulations to inform the optimal use of CAB-LA.

Keyphrases

healthcare
antiretroviral therapy
hiv infected
human immunodeficiency virus
hepatitis c virus
hiv positive
hiv aids
emergency department
current status